CAP

With the calendar winding down and the House without a speaker, the PAMA reform bill could stall again this year, though another temporary fix may be in the offing.

Organization leaders said this week they are studying proposed regulatory changes and advocating on multiple fronts against cuts in payment to pathologists.

The projects signal ongoing concern among health regulators about the quality and regulation of lab-developed tests used to guide cancer treatment and gauge disease risk.